Myopia (shortsightedness) is increasing in prevalence worldwide. Not only does it result in a lifetime of handicap and inconvenience it also carries addition risks of eye disease and blindness. Recent evidence shows that myopia progression can be slowed or halted in children and teenagers.
There are three key methods that have gained scientific support for myopia control. These are
Orthokeratology, or OrthoK, involves the use of specially designed rigid gas-permeable (RGP) contact lenses to alter the shape of the cornea to reduce or correct myopia (short-sightedness). The lens itself doesn’t touch the cornea, it uses a specially shaped layer of tears between the lens and the eye to gently reshape the front of the eye. This provides good vision without spectacles or contact lenses for most of the day. It does not hurt and using well established contact lens fitting techniques there are few risks.
MiSight [link] uses soft daily disposable contact lenses that are specially designed to have a myopia controlling effect. This daily soft lens now extends the range of options available for the management and control of myopia.
Low (0.01%) dose Atropine eyedrops. The Singapore Atropine for the Treatment of Myoia (ATOM) Trials demonstrated the effectiveness of low dose atropine in slowing the progression of myopia with minimal side effects. Low dose Atropine is now considered standard care for myopia progression in many Asian countries where the incidence of Myopia can be as high as 90%.
Evidence also suggests that increased time outdoors in natural light is protective against myopia.
These methods can be used alone or in combination. Following an in-depth consultation we can advise on the most appropriate course of action